Fifth Third Bancorp
BNTC icon

Fifth Third Bancorp’s Benitec Biopharma BNTC Stock Holding History

Fifth Third Bancorp’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
140
+34
+32% +$403 ﹤0.01% 4095
2026
Q1 		$1.13K Buy
+106
New +$1.23K ﹤0.01% 4117

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Fifth Third Bancorp's BNTC Position: Q2 2026 in Review

Fifth Third Bancorp increased its Benitec Biopharma (BNTC) stake by 32% in Q2 2026, buying an estimated $403 and bringing the position to 140 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #4095.

Fifth Third Bancorp first reported a position in BNTC in Q1 2026 and has held it in 2 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Fifth Third Bancorp held 140 shares of Benitec Biopharma worth $1.87K as of Q2 2026.
  • Fifth Third Bancorp bought 34 Benitec Biopharma shares in Q2 2026, an estimated $403.
  • Benitec Biopharma made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4095 holding.
  • Fifth Third Bancorp first reported a position in Benitec Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.